Particle Therapy 2017

495 / 1416

High risk 709(54%)
Interm risk 378(29%)
Low risk 218(17%)
Total 1305
Approval of HAMT
16f./4wks
Phase
I/II
Phase
II
Therapeutic results – The NIRS experience with carbon ions